MTOR and hepatocellular carcinoma: The expression of pre-S2 mutants in transgenic mice results in liver inflammation and fibrosis, hepatomegaly, and HCC formation, along with the consistent activation of mTOR signal pathways throughout the liver tumorigenesis [18].